Tempus AI, Inc. (TEM)
NASDAQ
Real-time Data
01:30 PM
Day's Range
65.2552 wk Range
40.77Overview - TEM - Tempus AI, Inc.
Key Statistics
Valuation
Enterprise Value
13.74B
P/E (Trailing)
‪39.29‬
P/E (Forward)
‪-4,782.23‬
PEG Ratio
‪-0.35‬
Price / Sales (TTM)
‪9.15‬
Price / Book
‪29.41‬
EV / EBITDA
‪-71.07‬
Profitability
Gross Margin
‪64.44%‬
Profit Margin
‪-17.76%‬
Operating Margin
‪-20.10%‬
Return on Assets
‪-8.54%‬
Return on Equity
‪-67.44%‬
Ownership
Shares Outstanding
180.24M
Float
115.47M
Short % of Shares Outstanding
‪33.27%‬
Held by Insiders
‪36.78%‬
Held by Institutions
‪59.15%‬
Price stats
Beta
‪3.57‬
50-Day Avg
‪52.66‬
200-Day Avg
‪56.78‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
16 analysts
Average price target
‪$ 62.64‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - TEM - Tempus AI, Inc.
Peers - TEM - Tempus AI, Inc.
Peer Comparison
Compared with companies in Health Information Services listed on NASDAQ.
Profile Summary - TEM - Tempus AI, Inc.
About
Tempus AI, Inc. is a healthcare technology company that applies artificial intelligence and machine learning to clinical and molecular data to support medical decision-making. The company operates a data and analytics platform designed to structure, integrate, and analyze diverse healthcare information, including…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
